EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark CROSSFIRE ONCOLOGY was filed as Word mark on 04/12/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/04/2023.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018861171 |
| Application date | April 12, 2023 |
| Publication date | June 27, 2023 |
| Entry date | October 4, 2023 |
| Expiration date | April 12, 2033 |
Trademark owner
Kloosterstraat 9
5349 AB Oss
NL
5349 AB Oss
NL
Trademark representatives
Keizerstraat 7
4811 HL Breda
NL
goods and services
1
chemicals for science; Chemical preparations, including the following products: Biochemical preparations for protein purification and drug identification; research reagents for scientific or research use, including the following products: Reagents for medical research; monoclonal antibodies for diagnostic use or for scientific use, other than for medical use; Kinase or other enzyme inhibitors; Parts for the aforesaid goods included in this class
5
Enzymes for medical purposes; Medicine, including the following products: Anti-cancer drugs; Pharmaceutical drugs; Compounds for treating cancer; Anti-cancer preparations of chemical origin; Pharmaceutical preparations for treating malignant tumors; Tumour antigens; Tumor suppressing agents; Reagents for medical use; Clinical medical reagents; Parts for the aforesaid goods, included in this class
35
Commercial intermediation services; Office functions; Purchasing services; Wholesaling and retailing in relation to the following goods: Chemical products for scientific purposes, chemical substances, Including biochemical preparations for protein purification and drug identification, Reagents For scientific or research use, Including reagents for medical research and Parts of the aforementioned goods; Wholesaling and retailing in relation to the following goods: Monoclonal antibodies for use in diagnosis or For scientific use, not for medical purposes, Enzymes for medical purposes, Kinase or other enzyme inhibitors; Wholesale and retail services relating to medicines, including anti-cancer drugs, drugs, compounds for treating cancer, anti-cancer preparations of chemical origin, pharmaceutical preparations for treating malignant tumours, tumour antigens, tumour-suppressing agents, reagents for medical use, clinical medical reagents; Import and export services; Online ordering services; Provision of commercial information; Promotion services; Organisation of events for commercial and advertising purposes; Consultancy and information regarding the aforesaid services; Providing the aforesaid services, including via electronic networks, such as the Internet
42
Scientific research for medical purposes in the area of cancerous diseases; Development of pharmaceutical preparations and medicines; Science and technology services, in the following fields: Identification and characterisation of enzymes, in particular kinase; Research into the determination of the binding kinetics of a compound, such as a drug; Conducting of protein kinase and enzyme assays; Research laboratories; Research laboratories, in the following fields: cancer biology; Drawing up of expert reports by laboratory technicians; Medical research; Research relating to biotechnology; Testing of substances, medicines and pharmaceutical preparations; Consultancy relating to research and development in the field of medicines and pharmaceutical preparations; Development relating to the following goods: Kinase inhibitors and other enzyme inhibitors; Research and development services in the field of antibodies; Consultancy and information regarding the aforesaid services, including via electronic networks, such as the Internet
ID: 11018861171